These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 22893324)
1. Platelet function and constituents of platelet rich plasma. Pelletier MH; Malhotra A; Brighton T; Walsh WR; Lindeman R Int J Sports Med; 2013 Jan; 34(1):74-80. PubMed ID: 22893324 [TBL] [Abstract][Full Text] [Related]
2. Autologous platelet gel: an in vitro analysis of platelet-rich plasma using multiple cycles. Christensen K; Vang S; Brady C; Isler J; Allen K; Anderson J; Holt D J Extra Corpor Technol; 2006 Sep; 38(3):249-53. PubMed ID: 17089512 [TBL] [Abstract][Full Text] [Related]
3. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production. Levin E; Culibrk B; Gyöngyössy-Issa MI; Weiss S; Scammell K; LeFresne W; Jenkins C; Devine DV Transfusion; 2008 Nov; 48(11):2331-7. PubMed ID: 18631169 [TBL] [Abstract][Full Text] [Related]
4. [Assessment study on a set of platelet-rich plasma preparation]. Li M; Zhang C; Yuan T; Chen S; Lü R Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2011 Jan; 25(1):112-6. PubMed ID: 21351624 [TBL] [Abstract][Full Text] [Related]
5. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Sundman EA; Cole BJ; Fortier LA Am J Sports Med; 2011 Oct; 39(10):2135-40. PubMed ID: 21846925 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of factors that can modify platelet-rich plasma properties. Andrade MG; de Freitas Brandão CJ; Sá CN; de Bittencourt TC; Sadigursky M Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jan; 105(1):e5-e12. PubMed ID: 18155603 [TBL] [Abstract][Full Text] [Related]
7. Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems. Castillo TN; Pouliot MA; Kim HJ; Dragoo JL Am J Sports Med; 2011 Feb; 39(2):266-71. PubMed ID: 21051428 [TBL] [Abstract][Full Text] [Related]
8. Correlation of platelet concentration in platelet-rich plasma to the extraction method, age, sex, and platelet count of the donor. Weibrich G; Kleis WK; Kunz-Kostomanolakis M; Loos AH; Wagner W Int J Oral Maxillofac Implants; 2001; 16(5):693-9. PubMed ID: 11669252 [TBL] [Abstract][Full Text] [Related]
9. Clot lysis time in platelet-rich plasma: method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acid. Panes O; Padilla O; Matus V; Sáez CG; Berkovits A; Pereira J; Mezzano D Platelets; 2012; 23(1):36-44. PubMed ID: 21787173 [TBL] [Abstract][Full Text] [Related]
10. Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation. Everts PA; Hoffmann J; Weibrich G; Mahoney CB; Schönberger JP; van Zundert A; Knape JT Transfus Med; 2006 Oct; 16(5):363-8. PubMed ID: 16999760 [TBL] [Abstract][Full Text] [Related]
11. The contribution of platelets in the production of cryoprecipitates for use in a fibrin glue. Rock G; Neurath D; Lu M; Alharbi A; Freedman M Vox Sang; 2006 Oct; 91(3):252-5. PubMed ID: 16958838 [TBL] [Abstract][Full Text] [Related]
12. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Dohan Ehrenfest DM; Rasmusson L; Albrektsson T Trends Biotechnol; 2009 Mar; 27(3):158-67. PubMed ID: 19187989 [TBL] [Abstract][Full Text] [Related]
13. Avoiding leukocyte contamination and early platelet activation in platelet-rich plasma. Trindade-Suedam IK; Leite FR; de Morais JA; Leite ER; Marcantonio EJ; Leite AA J Oral Implantol; 2007; 33(6):334-9. PubMed ID: 18240792 [TBL] [Abstract][Full Text] [Related]
14. Microbicidal properties of Leukocyte- and Platelet-Rich Plasma/Fibrin (L-PRP/L-PRF): new perspectives. Cieslik-Bielecka A; Dohan Ehrenfest DM; Lubkowska A; Bielecki T J Biol Regul Homeost Agents; 2012; 26(2 Suppl 1):43S-52S. PubMed ID: 23648198 [TBL] [Abstract][Full Text] [Related]
15. Platelet-rich plasma preparation using three devices: implications for platelet activation and platelet growth factor release. Everts PA; Brown Mahoney C; Hoffmann JJ; Schönberger JP; Box HA; van Zundert A; Knape JT Growth Factors; 2006 Sep; 24(3):165-71. PubMed ID: 17079200 [TBL] [Abstract][Full Text] [Related]
16. Assessment of canine autologous platelet-rich plasma produced with a commercial centrifugation and platelet recovery kit. Frye CW; Enders A; Brooks MB; Struble AM; Wakshlag JJ Vet Comp Orthop Traumatol; 2016; 29(1):14-9. PubMed ID: 26603823 [TBL] [Abstract][Full Text] [Related]
17. In vitro platelet aggregation defects in patients with myeloproliferative disorders and high platelet counts: are they laboratory artefacts? Grignani C; Noris P; Tinelli C; Barosi G; Balduini CL Platelets; 2009 Mar; 20(2):131-4. PubMed ID: 19235056 [TBL] [Abstract][Full Text] [Related]
18. [Preparation of platelet-rich plasma gel and its effect on skin flap survival of rat]. Li W; Feng R Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 Jan; 26(1):64-9. PubMed ID: 22332522 [TBL] [Abstract][Full Text] [Related]
19. Bioactivity of freeze-dried platelet-rich plasma in an adsorbed form on a biodegradable polymer material. Nakajima Y; Kawase T; Kobayashi M; Okuda K; Wolff LF; Yoshie H Platelets; 2012; 23(8):594-603. PubMed ID: 22273512 [TBL] [Abstract][Full Text] [Related]
20. Platelet-rich plasma differs according to preparation method and human variability. Mazzocca AD; McCarthy MB; Chowaniec DM; Cote MP; Romeo AA; Bradley JP; Arciero RA; Beitzel K J Bone Joint Surg Am; 2012 Feb; 94(4):308-16. PubMed ID: 22336969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]